This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Incyte Corporation, Novartis Pharma Ag. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 687 
1 out of 37 
Years Active: 2018
Title: Paola Guglielmelli: Innovator in Cancer Therapy
Introduction
Paola Guglielmelli is a prominent inventor based in Florence, Italy. She has made significant contributions to the field of cancer therapy, particularly through her innovative patent involving combination therapies.
Latest Patents
Guglielmelli holds a patent for an mTOR/JAK inhibitor combination therapy. This groundbreaking therapy comprises an mTOR inhibitor and a JAK inhibitor, which is useful for treating various cancers, including myeloproliferative neoplasms. Additionally, this combination therapy is beneficial for treating several JAK-associated diseases.
Career Highlights
Throughout her career, Guglielmelli has worked with notable companies such as Novartis Pharma AG and Incyte Corporation. Her work in these organizations has allowed her to develop and refine her innovative approaches to cancer treatment.
Collaborations
Some of her notable coworkers include Alessandro M. Vannucchi and Costanza Bogani. Their collaborative efforts have contributed to advancements in cancer research and therapy.
Conclusion
Paola Guglielmelli's contributions to cancer therapy through her innovative patent highlight her role as a leading inventor in the medical field. Her work continues to impact the treatment of cancer and related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile